30 Nov 2014 | News
Title: Engineered Rabbit Antibody Variable Domains and Uses Thereof Office: Australia Patents Office Date: 16/10/2007 Patent no: 2008246442
31 Jul 2014 | News
TECHNOPHAGE, a biotechnology company headquartered in Lisbon, Portugal, announced today that the company has received authorization from U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application for TP-102, a bacteriophage cocktail for...
20 Jul 2014 | News
New patent granted to TechnoPhage: Title: Antibacterial Phage, Phage Peptides and Methods Of Use Thereof Office: The Registry of Patents Singapore Date: 17/7/2014 Patent no: 173533
4 Jul 2014 | News
TECHNOPHAGE and SIMM, SHANGHAI INSTITUTE OF MATERIA MEDICA, a state-owned Institute administered and existing under the laws of the People’s Republic of China, have signed today a collaboration agreement for the joint development of a new pharmaceutical drug,...
14 Mai 2014 | News
TECHNOPHAGE and UNIVERSITY OF MACAU, a University administered and existing under the laws of Macau Special Administrative Region, China, have signed today a Statement of Work relating to the development of new therapeutics directed at ageing-related diseases,...
